XML 93 R80.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Development, Commercialization and Supply Agreements - Summary of Transaction Price Comprising Upfront Payments and Milestones (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Oct. 31, 2023 | Jan. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2018 | Sep. 30, 2017 | Mar. 31, 2017 | Mar. 31, 2016 | Feb. 28, 2015 | Dec. 31, 2024
Edding |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Regulatory development support |  |  |  |  |  |  |  |  |  | $ 1,081
Total Trasanction Price |  |  |  |  |  |  |  |  |  | 40,081
Edding | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable up-front received |  |  |  |  |  |  |  |  | $ 15,000 |
Edding | Clinical Trial Application | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received |  |  |  |  |  |  |  | $ 1,000 |  |
Edding | Achievement of REDUCE-IT Trial | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received |  | $ 3,000 |  |  |  |  |  |  |  |
Edding | VASCEPA | MARINE | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received |  |  |  |  |  |  | $ 5,000 |  |  |
Edding | VASCEPA | Achievement of REDUCE-IT Trial |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received | $ 15,000 |  |  |  |  |  |  |  |  |
HLS |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Total Trasanction Price |  |  |  |  |  |  |  |  |  | $ 13,800
HLS | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable up-front received |  |  |  |  |  | $ 5,000 |  |  |  |
Non-refundable milestone payment received |  |  | $ 3,800 |  |  |  |  |  |  |
HLS | Out-licenses | Health Canada |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received |  |  |  | $ 2,500 |  |  |  |  |  |
HLS | Achievement of REDUCE-IT Trial | Out-licenses |  |  |  |  |  |  |  |  |  |
License And Collaboration Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Non-refundable milestone payment received |  |  |  |  | $ 2,500 |  |  |  |  |

X
- Definition License And Collaboration Agreements [Line Items] + References No definition available. + Details
Name: | amrn_LicenseAndCollaborationAgreementsLineItems
Namespace Prefix: | amrn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Non refundable upfront payments received. + References No definition available. + Details
Name: | amrn_NonRefundableUpfrontPaymentsReceived
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Nonrefundable milestone payment received. + References No definition available. + Details
Name: | amrn_NonrefundableMilestonePaymentReceived
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Nonrefundable upfront and milestone payment received. + References No definition available. + Details
Name: | amrn_NonrefundableUpfrontAndMilestonePaymentReceived
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Regulatory development support + References No definition available. + Details
Name: | amrn_RegulatoryDevelopmentSupport
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | amrn_BusinessDevelopmentsAxis=amrn_EddingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=amrn_OutLicensesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=amrn_ClinicalTrialApplicationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=amrn_AchievementOfReduceItTrialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amrn_VascepaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=amrn_MarineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | amrn_BusinessDevelopmentsAxis=amrn_HLSTherapeuticsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=amrn_HealthCanadaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |